Description: VYZULTA® is a dual-action prostaglandin analog that can provide well-tolerated and sustained IOP reduction for patients with open-angle glaucoma or ocular hypertension
safety (4378) glaucoma (484) moa (89) efficacy (32) nitric oxide (27) vyzulta hcp (1) open-angle glaucoma (1) dual moa (1)
Significantly greater intraocular pressure (IOP) reduction vs timolol 0.5% or Xalatan (latanoprost) 0.005% in clinical trials 1-4
Cancel Confirm
VYZULTA ® (latanoprostene bunod ophthalmic solution), 0.024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.